About Gila Therapeutics
Gila Therapeutics is a private company based in Edina, Minnesota. It has reported $5,664,413 raised in six offerings on Form D since May 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 22, 2023 | Dec 6, 2023 | $399,572of $10.0M target | 7 | $57,082 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 15, 2022 | Nov 29, 2022 | $355,522of $5.0M target | 6 | $59,254 | EquityRule 506(b) | Form D ↗ |
| Jan 29, 2021 | Feb 16, 2021amended Nov 12, 2021 | $1,250,000fully sold | 28 | $44,643 | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 4, 2019 | Mar 13, 2019 | $314,434of $2.0M target | 3 | $104K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Feb 13, 2017 | $0of $500K target | 0 | — | EquityRule 506(c) | Form D ↗ |
| Apr 15, 2016 | May 2, 2016amended Apr 18, 2017 | $3,344,885of $4.0M target | 33 | $101K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, six offerings | $5,664,413 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gila Therapeutics's Form D filed Dec 6, 2023.
TB
Timothy Barberich
Director
CS
Christopher De Souza
Director
PT
Praveen Tyle
Director
JF
Jon Freeman
Executive officer
TV
Thomas Vasicek
Executive officer
RH
Richard Horan
Director
SS
Scott Schorer
Cief Executive Officer and director
SK
Sangeeta Kashyap
Executive officer
Earlier filings also listed Sergei Zolutukhin (promoter, last listed Apr 2017) and Andres Acosta (promoter, last listed Apr 2017).